Pharmacokinetic and pharmacodynamic studies for medications development. POP: 9/20/2017-9/19/2022. N01DA-17-8935.
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN271201700056C
- Awardee
-
Altasciences Clinical Kansas Inc. UEI WZ5RGEMMQ3W9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,562,513
Award facts
- Opportunity
-
- N01DA178935 Solicitation number
- Pharmacokinetic and Pharmacodynamic Studies for Medications Development Award Notice · Posted Apr 1, 2017
- Contract value 100% obligated
- $3,562,513.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Shawnee Mission, KS 66212, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $146,129 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Exercise an Option | $1,357,821 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,334,220 | |
| Original award | $724,343 |
About this award
This is a $3,562,513 cost-plus-fixed-fee definitive contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to Altasciences Clinical Kansas Inc. The contract is for pharmacokinetic and pharmacodynamic studies to support the development of medications for substance use disorders. The contract period of performance is from September 20, 2017 to September 19, 2022, with an ultimate completion date of July 31, 2025. This award is not associated with any set-aside. Altasciences Clinical Kansas Inc. is a for-profit contract research organization that specializes in early-phase drug development services. The purpose of this contract is to provide clinical pharmacology research services to support NIDA's mission of advancing treatments for substance use disorders.
Quick answers
Who was awarded contract HHSN271201700056C?
HHSN271201700056C was awarded to Altasciences Clinical Kansas Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2017.
How much is contract HHSN271201700056C worth?
The government has obligated $3,562,513 on HHSN271201700056C.
Was contract HHSN271201700056C competed?
The extent of competition for HHSN271201700056C was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award